Sfoglia per Autore
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome
2016 E. Nuri, M. Taraborelli, L. Andreoli, M. Tonello, M. Gerosa, A. Calligaro, L.M. Argolini, R. Kumar, V. Pengo, P.L. Meroni, A. Ruffatti, A. Tincani
The use of biologics and small molecules in pregnant patients with rheumatic diseases
2018 M. Gerosa, L.M. Argolini, C. Artusi, C.B. Chighizola
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up
2020 L.M. Argolini, G. Frontini, E. Elefante, F. Saccon, V. Binda, C. Tani, I. Scotti, L. Carli, M. Gatto, C. Esposito, M. Gerosa, R. Caporali, A. Doria, P. Messa, M. Mosca, G. Moroni
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology
2022 A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L.M. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani
Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients
2022 T. Schioppo, L.M. Argolini, S. Sciascia, F. Pregnolato, F. Tamborini, P. Miraglia, D. Roccatello, R.A. Sinico, R. Caporali, G. Moroni, M. Gerosa
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination
2022 G.A. Ramirez, L.M. Argolini, T. Schioppo, S. Sciascia, L. Moroni, G. Moroni, R.A. Sinico, G. Bonelli, F. Alberici, F. Mescia, F. Tamborini, P. Miraglia, C. Bellocchi, L. Beretta, D. Roccatello, E.P. Bozzolo, R. Caporali, M. Gerosa, L. Dagna
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
2022 M. Gerosa, L. Beretta, G.A. Ramirez, E. Bozzolo, M. Cornalba, C. Bellocchi, L.M. Argolini, L. Moroni, N. Farina, G. Segatto, L. Dagna, R. Caporali
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile